Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, Yuanxin Xi et al.|Cancer Cell|2021Cited by 930
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid culturesCarminia Maria Della Corte, Floriana Morgillo|Journal of Experimental & Clinical Cancer Research|2019Cited by 105
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFRCarminia Maria Della Corte, Floriana Morgillo|Oncotarget|2017Cited by 40
Impact of a Cardio-Oncology Unit on Prevention of Cardiovascular Events in Cancer PatientsAlessandra Cuomo, Carlo G. Tocchetti, Valentina Mercurio et al.|ESC Heart Failure|2022Cited by 22
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologistsMargaret Ottaviano, Vincenzo Montesarchio, Marcello Curvietto et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 19